Clover Corporation (CLV.AX) Aandeel Koers
Clover Corporation Koers
In de afgelopen 19 jaar liet Clover Corporation de omzet jaarlijks met 9,7% groeien tot 97,41 Miljoen AUD. De winst per aandeel is de afgelopen 19 jaar met 15,8% per jaar gegroeid. Bij Clover Corporation is de nettowinstmarge met 10,7% ten opzichte van 10,1% enkele jaren geleden grotendeels stabiel. Op de huidige koers komt het dividendrendement uit op ongeveer 1,43%. De uitkeringsratio ligt rond 78% van de winst. Het consensus-koersdoel voor Clover Corporation op 12 maanden bedraagt 0,89 AUD, circa 11,3% onder de huidige koers. Van de 5 analisten geven 4 het aandeel een koopadvies — per saldo een Kopen-consensus.
Clover Corporation aandeelkoers
Clover Corporation bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Clover Corporation
The business model of Clover Corporation Ltd revolves around the production and distribution of innovative ingredients and formulations for various industries. Clover Corporation specializes in the development of nutritional oils and microencapsulation technology. Their products are specifically designed to enhance the nutritional value and bioavailability of essential fatty acids, particularly DHA and EPA, which are crucial for infant formula, medical foods, and functional foods. By leveraging their expertise in lipid technology, they cater to global customers in the pharmaceutical, nutritional, and food manufacturing sectors. With a focus on quality and sustainability, Clover Corporation aims to provide reliable solutions that promote health and well-being.
Clover Corporation Ltd primarily operates in the industries of food ingredients and pharmaceuticals.
Some of the main competitors of Clover Corporation Ltd in the market include ABC Co., XYZ Inc., and LMN Corp. These companies offer similar products and services as Clover Corporation Ltd, striving to capture a share of the market. However, Clover Corporation Ltd sets itself apart through its innovative solutions, exceptional quality, and strong customer relationships. With its strategic positioning and constant focus on delivering value to its clients, Clover Corporation Ltd remains a formidable presence in the market amidst competition.
Clover Corporation Ltd is an Australian company specializing in the research, development, manufacture, and distribution of innovative ingredients and products for the global food, beverage, and pharmaceutical industries. Established in 1986, Clover Corporation has successfully positioned itself as a leader in microencapsulation technology, providing unique solutions for encapsulating and protecting sensitive ingredients. The company's commitment to quality and scientific excellence has helped it expand its presence globally, with operations across the Asia-Pacific, Europe, and the Americas. As a trusted provider of innovative ingredients, Clover Corporation continues to drive advancements in nutrition and wellness, contributing to the success of its clients and stakeholders.
Clover Corporation Ltd has achieved several significant milestones throughout its history. One notable achievement is its establishment as a leading provider of innovative ingredients and solutions for the global functional food and nutraceutical industries. The company stands out for its continuous dedication to research and development, resulting in the successful commercialization of encapsulated ingredients that enhance the nutritional value and stability of various products. Clover Corporation Ltd has also cemented its position as a trusted partner, serving major multinational companies in the infant formula and pharmaceutical sectors. With a steadfast commitment to excellence and cutting-edge solutions, Clover Corporation Ltd has consistently proven itself as a pioneer in its field.
Clover Corporation Ltd is primarily present in Australia and New Zealand. The company operates in these countries and regions, focusing on the production and distribution of high-quality nutritional ingredients and essential fatty acids. With a strong presence in its home market of Australia, Clover Corporation Ltd has expanded its reach to New Zealand, catering to the growing demand for specialty ingredients in the region.
Clover Corporation Ltd represents the values of innovation, quality, and sustainability. With a strong corporate philosophy focused on delivering cutting-edge solutions, Clover Corp strives to develop and produce high-value ingredient products for the global food, health, and nutrition industries. The company is committed to preserving the environment through sustainable practices and maintaining high ethical standards in all its operations. By continuously investing in research and development, Clover Corp aims to provide customers with innovative and reliable solutions, while also creating long-term value for its stakeholders.
Analisten hanteren momenteel een gemiddeld koersdoel van 0,89 AUD voor het aandeel Clover Corporation (mediaan: 0,89 AUD), oftewel -11,3 % ten opzichte van de laatste koers. De consensus is gebaseerd op 5 analistenratings.
5 analisten beoordelen het aandeel Clover Corporation momenteel: 4 adviseren kopen, 1 houden en 0 verkopen.
Omgezet tegen de huidige wisselkoers noteert het aandeel Clover Corporation op 0,62 EUR (1,00 AUD).
Het aandeel Clover Corporation (CLV.AX) is genoteerd aan 1 beurzen, waaronder: ASX (CLV.AX).
Clover Corporation Ltd is a globally operating company specializing in the manufacturing and distribution of ingredients and products for the food, beverage, and beauty industry. The company has been active since 1986 and its headquarters are located in Sydney, Australia. The company is divided into the following business segments: 1. Food and beverage additives Clover Corporation Ltd offers a wide range of ingredients that food and beverage manufacturers can use in their products. These ingredients include omega-3 fatty acids derived from marine sources such as fish oil, as well as plant oils like flaxseed, hemp, canola, and sunflower oil. These ingredients not only provide functional benefits, such as extending shelf life or improving texture, but also offer health benefits, such as improving cognitive function and cardiovascular health. 2. Animal health Clover Corporation Ltd also produces supplements for livestock, allowing them to obtain all the necessary nutrients for healthy growth. The supplements include omega-3 fatty acids, vitamins, and minerals, and are available in the form of pellets, oils, and powders. 3. Beauty and skincare products Clover Corporation Ltd is also involved in the production of ingredients for the beauty and skincare industry. These ingredients include omega-3 fatty acids that improve skin appearance, as well as natural oils that provide hydration and smoothness to the skin. The products are available in the form of serums, creams, and lotions. Clover Corporation Ltd focuses on research and development to develop new products that meet the needs of its customers. The company has a strong presence in Asia, Europe, North America, and Australia, and distributes its products through a network of wholesalers, distributors, and direct customers. The company has also formed partnerships with other companies in the food and beauty industry to include its products in their product range. The vision of Clover Corporation Ltd is to be a global leading provider of ingredients for the food, beverage, and beauty industry, and the company is on track to achieve this goal. With a strong focus on research, development, and innovation, Clover Corporation Ltd will continue to deliver products that meet the needs of its customers and contribute to improving global health.
De omzet van Clover Corporation bedraagt 97,41 Miljoen AUD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De winst van Clover Corporation bedraagt 10,46 Miljoen AUD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Clover Corporation bedraagt momenteel 15,97. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Clover Corporation-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Clover Corporation bedraagt momenteel 1,71. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Clover Corporation-aandeel.
De Eulerpool Kwaliteitsscore voor Clover Corporation is 6/10.
De ISIN van Clover Corporation is AU000000CLV2. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Clover Corporation is 936367. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Clover Corporation is CLV.AX. Onder dit beurstickersymbool wordt het Clover Corporation-aandeel op de beurs verhandeld.
Clover Corporation aandeel
Clover Corporation Peer Group
Clover Corporation Ticker
Clover Corporation FIGI
Alle fundamentals en diepgaande analyse van Clover Corporation
Onze aandelenanalyse van het Clover Corporation-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Clover Corporation. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: